五聚体复合物基因多态性与临床巨细胞病毒分离株中和关系分析
研究对25株日本临床巨细胞病毒分离株的五聚体复合物(gH/gL/UL128/UL130/UL131A)编码基因测序,用两种血清阳性人血清和抗五聚体血清在ARPE-19报告细胞系中测定中和。UL128、UL130和UL131A氨基酸多态性有限并聚为两大组,除UL128 I140T外均位于已知中和抗体识别区外;抗五聚体血清以相似程度中和所有分离株,与多态性分组无相关性。结论提示Merlin Fix株制备的五聚体抗原诱导的抗体可相似水平中和所有分离株,且抗五聚体抗体中和CMV感染优于人血清。
要点
- 25株日本临床分离株的五聚体基因序列多态性有限,聚为两大组。
- 除UL128 I140T外,鉴定的氨基酸改变位于已知中和抗体识别区外。
- 抗五聚体血清以相似程度中和所有分离株,与多态性分组无相关性。
核心结论
- Merlin Fix株制备的五聚体抗原诱导的抗体以相似水平中和所有临床分离株。
- 抗五聚体抗体中和CMV感染优于人血清,提示基于五聚体抗原的疫苗和治疗性抗体具有一定前景。
研究设计与样本
- 测定25株日本临床分离株五聚体组分编码基因序列。
- 用两种血清阳性人血清和抗五聚体血清,在基于ARPE-19的CMV报告细胞系中测定中和。
主要发现
- UL128、UL130和UL131A开放阅读框氨基酸序列多态性有限并聚为两大组。
- 除UL128 I140T外,鉴定的改变位于已报道的中和抗体识别区外。
- 抗五聚体血清以相似程度中和所有分离株,与多态性分组无相关性。
临床怎么用
- 原文提示基于五聚体抗原的疫苗和治疗性抗体研发具有一定前景。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: As congenital cytomegalovirus (CMV) infection is one of the major causes of birth defects and developmental abnormalities, it is essential to develop vaccines and therapeutic antibodies against CMV. Clinical trials demonstrated that the subunit vaccine based on glycoprotein B, which had been believed to be the major target for neutralization, did not induce sufficient protective immunity. On the other hand, it has been reported that the immunization of animals with the Pentamer, the pentameric complex of gH/gL/UL128/UL130/UL131A, induced strong neutralizing antibodies. Here, we sought to clarify whether any polymorphic alterations present in the Pentamer of clinical isolates affect neutralization by anti-Pentamer antibodies. METHODS: Sequences of the genes encoding the Pentamer components of 25 Japanese clinical isolates were determined. Neutralization of infection by two seropositive sera and by anti-Pentamer serum was measured using a CMV reporter cell line based on ARPE-19. RESULTS: Polymorphisms of the amino acid sequence of UL128, UL130, and UL131A ORFs were limited and clustered into two major groups. The identified alterations, except UL128 I140T, were mapped outside of the reported regions recognized by neutralizing antibodies. Anti-Pentamer serum neutralized infection with all isolates to a similar degree and had no correlation with the polymorphic groups. CONCLUSIONS: Our findings indicate that Pentamer antigens prepared from Merlin Fix strain induce antibodies that neutralize infection with all isolates to a similar level and that anti-Pentamer antibodies neutralize CMV infection better than do human sera, suggesting that vaccines and therapeutic antibodies based on Pentamer as an antigen have some promise.
引用
- Kobayashi R, Abe M, Oguri K, et al. Analysis of relationships between polymorphisms in the genes encoding the pentameric complex and neutralization of clinical cytomegalovirus isolates. Vaccine. 2018. PMID: 30174240. doi:10.1016/j.vaccine.2018.08.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。